- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
|SiMPore's 15 nanometer thick ultrathin membrane enables precise and rapid separation of biological molecules and other nanomaterials.|
SiMPore, Inc. has been selected to present at the upcoming NSTI Nanotech Ventures in Boston, June 3-5, 2008. Mr. Thomas Gaborski, Co-Founder and Vice President of Business Development for SiMPore, provided us with several update on the company and recent funding and development news.
CEO: Rick Richmond
Location: New York, USA
Industry: Pharma & Biotech
Venture is: Seed Level
SiMPore develops and produces ultra-thin nano-porous membrane filters and filtration products based on a new silicon membrane platform technology.
Membranes and membrane filters in use today are based on technology that dates from the mid-20th century. These filters are adequate for the microporous (one millionth of a meter) and submicroporous filtration for which they were initially developed.
With the advance of technology, biomedical research, pharmaceutical production and even industrial and consumer products have come to rely on nanoscale building blocks. Viruses, genes, proteins and nanoparticles are the new frontier. The need for filtration has expanded to include filtering and separating nanomaterials, not only for research and production, but also to protect from nanoparticle contamination in industrial processes and eliminating bio- and chemical hazards. Conventional polymer microporous membrane technology has attempted to address these needs for nanoporous filtration by tweaking microporous technology, but have not addressed many needs of the nano-world.
Mr. Gaborski tells the Nano World News that SiMPore is exclusively licensing this novel silicon membrane technology from the University of Rochester, where researchers and SiMPore co-founders have received over $1.5M in federal funding in the previous 12 months. In addition, SiMPore and the University of Rochester were awarded $473,000 in February by NYSTAR for the co-development and commercialization of SiMPore's porous silicon membrane for biomolecule filtration.
SiMPore is also pursuing industrial collaboration and is engaged in co-development talks with major filtration companies.
Currently, SiMPore is raising $500,000 in an angel round and expects to seek an A-round in 2009.
The Nano Science and Technology Institute (NSTI) is chartered with the promotion and integration of nano and other advanced technologies through education, technology and business development. NSTI accomplishes this mission through its offerings of continuing education programs, scientific and business publishing and community outreach. NSTI produces the annual Nanotech conference and trade show, the most comprehensive international nanotechnology convention in the world. NSTI also produces the semi-annual Nanotech Venture, Nanotech Industrial Impact Workshop, Nano Impact Summit and the Nanotech Course Series in the US and Europe. NSTI was founded in 1997 as a result of the merger between various scientific societies, and is headquartered in Cambridge, Massachusetts with additional offices in California and Switzerland.
For more information, please click here
696 San Ramon Valley Blvd., Ste. 423
Danville, CA 94526
Ph: (925) 901-4959
Fax: (925) 886-8461
Copyright © NSTIIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016
Designing ultrasound tools with Lego-like proteins August 29th, 2016
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
Meteorite impact on a nano scale August 29th, 2016
Stretchy supercapacitors power wearable electronics August 25th, 2016
Semblant to Present at China Mobile Manufacturing Forum 2016 August 25th, 2016
Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016